Lawyers for marijuana reform opponents that are participating in a Drug Enforcement Administration (DEA) hearing on the Trump administration’s cannabis rescheduling proposal put significant focus on the second day of the proceedings on pressing a government witness about recently adopted changes to an analysis used to determine whether drugs have accepted medical value. A separate government witness […]